A Phase 1 trial is the initial stage of human clinical research, typically involving a small group of healthy volunteers or patients. Its primary goal is to evaluate the safety profile of a new drug or treatment, determine appropriate dosage ranges, and identify potential side effects. This phase precedes Phase 2 and Phase 3 trials, which focus on efficacy and broader patient populations, making it a crucial step in the regulatory approval process.